カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のリツキシマブ用バイオシミラー市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Biosimilars of Rituximab Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19178）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19178
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：108
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のリツキシマブ用バイオシミラー市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

リツキシマブ用バイオシミラー市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のリツキシマブ用バイオシミラーの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

リツキシマブ用バイオシミラー市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・500mg、100mg、その他

用途別セグメントは次のように区分されます。
・病院調剤薬局、小売調剤薬局

世界のリツキシマブ用バイオシミラー市場の主要な市場プレーヤーは以下のとおりです。
・Amgen、AryoGen Pharmed、Biocad、Cadila Pharmaceuticals、Celltrion、Dr Reddy’s Laboratories、Teva、Hetero Group、Innovent Biologics、Intas Biopharmaceuticals、Mylan、Probiomed、TRPharma、Zenotech Laboratories

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、リツキシマブ用バイオシミラー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なリツキシマブ用バイオシミラーメーカーの企業概要、2019年～2022年までのリツキシマブ用バイオシミラーの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なリツキシマブ用バイオシミラーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別リツキシマブ用バイオシミラーの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのリツキシマブ用バイオシミラーの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのリツキシマブ用バイオシミラー市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびリツキシマブ用バイオシミラーの産業チェーンを掲載しています。
・第13、14、15章では、リツキシマブ用バイオシミラーの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- リツキシマブ用バイオシミラーの概要
- 種類別分析（2017年vs2021年vs2028年）：500mg、100mg、その他
- 用途別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局
- 世界のリツキシマブ用バイオシミラー市場規模・予測
- 世界のリツキシマブ用バイオシミラー生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Amgen、AryoGen Pharmed、Biocad、Cadila Pharmaceuticals、Celltrion、Dr Reddy’s Laboratories、Teva、Hetero Group、Innovent Biologics、Intas Biopharmaceuticals、Mylan、Probiomed、TRPharma、Zenotech Laboratories
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：500mg、100mg、その他
・用途別分析2017年-2028年：病院調剤薬局、小売調剤薬局
・リツキシマブ用バイオシミラーの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・リツキシマブ用バイオシミラーのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・リツキシマブ用バイオシミラーのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・リツキシマブ用バイオシミラーの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・リツキシマブ用バイオシミラーの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Biosimilars of Rituximab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biosimilars of Rituximab market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacy accounting for % of the Biosimilars of Rituximab global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 500mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Biosimilars of Rituximab include Amgen, AryoGen Pharmed, Biocad, Cadila Pharmaceuticals, and Celltrion, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosimilars of Rituximab market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
500mg
100mg
Other
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
The key market players for global Biosimilars of Rituximab market are listed below:
Amgen
AryoGen Pharmed
Biocad
Cadila Pharmaceuticals
Celltrion
Dr Reddy’s Laboratories
Teva
Hetero Group
Innovent Biologics
Intas Biopharmaceuticals
Mylan
Probiomed
TRPharma
Zenotech Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilars of Rituximab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilars of Rituximab, with price, sales, revenue and global market share of Biosimilars of Rituximab from 2019 to 2022.
Chapter 3, the Biosimilars of Rituximab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilars of Rituximab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilars of Rituximab market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars of Rituximab.
Chapter 13, 14, and 15, to describe Biosimilars of Rituximab sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Biosimilars of Rituximab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilars of Rituximab Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 500mg
1.2.3 100mg
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilars of Rituximab Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Global Biosimilars of Rituximab Market Size & Forecast
1.4.1 Global Biosimilars of Rituximab Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Biosimilars of Rituximab Sales in Volume (2017-2028)
1.4.3 Global Biosimilars of Rituximab Price (2017-2028)
1.5 Global Biosimilars of Rituximab Production Capacity Analysis
1.5.1 Global Biosimilars of Rituximab Total Production Capacity (2017-2028)
1.5.2 Global Biosimilars of Rituximab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilars of Rituximab Market Drivers
1.6.2 Biosimilars of Rituximab Market Restraints
1.6.3 Biosimilars of Rituximab Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Biosimilars of Rituximab Product and Services
2.1.4 Amgen Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AryoGen Pharmed
2.2.1 AryoGen Pharmed Details
2.2.2 AryoGen Pharmed Major Business
2.2.3 AryoGen Pharmed Biosimilars of Rituximab Product and Services
2.2.4 AryoGen Pharmed Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Biocad
2.3.1 Biocad Details
2.3.2 Biocad Major Business
2.3.3 Biocad Biosimilars of Rituximab Product and Services
2.3.4 Biocad Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cadila Pharmaceuticals
2.4.1 Cadila Pharmaceuticals Details
2.4.2 Cadila Pharmaceuticals Major Business
2.4.3 Cadila Pharmaceuticals Biosimilars of Rituximab Product and Services
2.4.4 Cadila Pharmaceuticals Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Celltrion
2.5.1 Celltrion Details
2.5.2 Celltrion Major Business
2.5.3 Celltrion Biosimilars of Rituximab Product and Services
2.5.4 Celltrion Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dr Reddy’s Laboratories
2.6.1 Dr Reddy’s Laboratories Details
2.6.2 Dr Reddy’s Laboratories Major Business
2.6.3 Dr Reddy’s Laboratories Biosimilars of Rituximab Product and Services
2.6.4 Dr Reddy’s Laboratories Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva Biosimilars of Rituximab Product and Services
2.7.4 Teva Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hetero Group
2.8.1 Hetero Group Details
2.8.2 Hetero Group Major Business
2.8.3 Hetero Group Biosimilars of Rituximab Product and Services
2.8.4 Hetero Group Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Innovent Biologics
2.9.1 Innovent Biologics Details
2.9.2 Innovent Biologics Major Business
2.9.3 Innovent Biologics Biosimilars of Rituximab Product and Services
2.9.4 Innovent Biologics Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Intas Biopharmaceuticals
2.10.1 Intas Biopharmaceuticals Details
2.10.2 Intas Biopharmaceuticals Major Business
2.10.3 Intas Biopharmaceuticals Biosimilars of Rituximab Product and Services
2.10.4 Intas Biopharmaceuticals Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business
2.11.3 Mylan Biosimilars of Rituximab Product and Services
2.11.4 Mylan Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Probiomed
2.12.1 Probiomed Details
2.12.2 Probiomed Major Business
2.12.3 Probiomed Biosimilars of Rituximab Product and Services
2.12.4 Probiomed Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 TRPharma
2.13.1 TRPharma Details
2.13.2 TRPharma Major Business
2.13.3 TRPharma Biosimilars of Rituximab Product and Services
2.13.4 TRPharma Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Zenotech Laboratories
2.14.1 Zenotech Laboratories Details
2.14.2 Zenotech Laboratories Major Business
2.14.3 Zenotech Laboratories Biosimilars of Rituximab Product and Services
2.14.4 Zenotech Laboratories Biosimilars of Rituximab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Biosimilars of Rituximab Breakdown Data by Manufacturer
3.1 Global Biosimilars of Rituximab Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Biosimilars of Rituximab Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Biosimilars of Rituximab
3.4 Market Concentration Rate
3.4.1 Top 3 Biosimilars of Rituximab Manufacturer Market Share in 2021
3.4.2 Top 6 Biosimilars of Rituximab Manufacturer Market Share in 2021
3.5 Global Biosimilars of Rituximab Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Biosimilars of Rituximab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biosimilars of Rituximab Market Size by Region
4.1.1 Global Biosimilars of Rituximab Sales in Volume by Region (2017-2028)
4.1.2 Global Biosimilars of Rituximab Revenue by Region (2017-2028)
4.2 North America Biosimilars of Rituximab Revenue (2017-2028)
4.3 Europe Biosimilars of Rituximab Revenue (2017-2028)
4.4 Asia-Pacific Biosimilars of Rituximab Revenue (2017-2028)
4.5 South America Biosimilars of Rituximab Revenue (2017-2028)
4.6 Middle East and Africa Biosimilars of Rituximab Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Biosimilars of Rituximab Sales in Volume by Type (2017-2028)
5.2 Global Biosimilars of Rituximab Revenue by Type (2017-2028)
5.3 Global Biosimilars of Rituximab Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Biosimilars of Rituximab Sales in Volume by Application (2017-2028)
6.2 Global Biosimilars of Rituximab Revenue by Application (2017-2028)
6.3 Global Biosimilars of Rituximab Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Biosimilars of Rituximab Sales by Type (2017-2028)
7.2 North America Biosimilars of Rituximab Sales by Application (2017-2028)
7.3 North America Biosimilars of Rituximab Market Size by Country
7.3.1 North America Biosimilars of Rituximab Sales in Volume by Country (2017-2028)
7.3.2 North America Biosimilars of Rituximab Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Biosimilars of Rituximab Sales by Type (2017-2028)
8.2 Europe Biosimilars of Rituximab Sales by Application (2017-2028)
8.3 Europe Biosimilars of Rituximab Market Size by Country
8.3.1 Europe Biosimilars of Rituximab Sales in Volume by Country (2017-2028)
8.3.2 Europe Biosimilars of Rituximab Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Biosimilars of Rituximab Sales by Type (2017-2028)
9.2 Asia-Pacific Biosimilars of Rituximab Sales by Application (2017-2028)
9.3 Asia-Pacific Biosimilars of Rituximab Market Size by Region
9.3.1 Asia-Pacific Biosimilars of Rituximab Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Biosimilars of Rituximab Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Biosimilars of Rituximab Sales by Type (2017-2028)
10.2 South America Biosimilars of Rituximab Sales by Application (2017-2028)
10.3 South America Biosimilars of Rituximab Market Size by Country
10.3.1 South America Biosimilars of Rituximab Sales in Volume by Country (2017-2028)
10.3.2 South America Biosimilars of Rituximab Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biosimilars of Rituximab Sales by Type (2017-2028)
11.2 Middle East & Africa Biosimilars of Rituximab Sales by Application (2017-2028)
11.3 Middle East & Africa Biosimilars of Rituximab Market Size by Country
11.3.1 Middle East & Africa Biosimilars of Rituximab Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Biosimilars of Rituximab Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Biosimilars of Rituximab and Key Manufacturers
12.2 Manufacturing Costs Percentage of Biosimilars of Rituximab
12.3 Biosimilars of Rituximab Production Process
12.4 Biosimilars of Rituximab Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Biosimilars of Rituximab Typical Distributors
13.3 Biosimilars of Rituximab Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Biosimilars of Rituximab Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biosimilars of Rituximab Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Biosimilars of Rituximab Product and Services
Table 6. Amgen Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AryoGen Pharmed Basic Information, Manufacturing Base and Competitors
Table 8. AryoGen Pharmed Major Business
Table 9. AryoGen Pharmed Biosimilars of Rituximab Product and Services
Table 10. AryoGen Pharmed Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Biocad Basic Information, Manufacturing Base and Competitors
Table 12. Biocad Major Business
Table 13. Biocad Biosimilars of Rituximab Product and Services
Table 14. Biocad Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Cadila Pharmaceuticals Major Business
Table 17. Cadila Pharmaceuticals Biosimilars of Rituximab Product and Services
Table 18. Cadila Pharmaceuticals Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Celltrion Basic Information, Manufacturing Base and Competitors
Table 20. Celltrion Major Business
Table 21. Celltrion Biosimilars of Rituximab Product and Services
Table 22. Celltrion Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dr Reddy’s Laboratories Major Business
Table 25. Dr Reddy’s Laboratories Biosimilars of Rituximab Product and Services
Table 26. Dr Reddy’s Laboratories Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Teva Basic Information, Manufacturing Base and Competitors
Table 28. Teva Major Business
Table 29. Teva Biosimilars of Rituximab Product and Services
Table 30. Teva Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Hetero Group Basic Information, Manufacturing Base and Competitors
Table 32. Hetero Group Major Business
Table 33. Hetero Group Biosimilars of Rituximab Product and Services
Table 34. Hetero Group Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 36. Innovent Biologics Major Business
Table 37. Innovent Biologics Biosimilars of Rituximab Product and Services
Table 38. Innovent Biologics Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Intas Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Intas Biopharmaceuticals Major Business
Table 41. Intas Biopharmaceuticals Biosimilars of Rituximab Product and Services
Table 42. Intas Biopharmaceuticals Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Major Business
Table 45. Mylan Biosimilars of Rituximab Product and Services
Table 46. Mylan Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Probiomed Basic Information, Manufacturing Base and Competitors
Table 48. Probiomed Major Business
Table 49. Probiomed Biosimilars of Rituximab Product and Services
Table 50. Probiomed Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. TRPharma Basic Information, Manufacturing Base and Competitors
Table 52. TRPharma Major Business
Table 53. TRPharma Biosimilars of Rituximab Product and Services
Table 54. TRPharma Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Zenotech Laboratories Basic Information, Manufacturing Base and Competitors
Table 56. Zenotech Laboratories Major Business
Table 57. Zenotech Laboratories Biosimilars of Rituximab Product and Services
Table 58. Zenotech Laboratories Biosimilars of Rituximab Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Biosimilars of Rituximab Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Biosimilars of Rituximab Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Biosimilars of Rituximab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Biosimilars of Rituximab Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Biosimilars of Rituximab Production Site of Key Manufacturer
Table 64. Biosimilars of Rituximab New Entrant and Capacity Expansion Plans
Table 65. Biosimilars of Rituximab Mergers & Acquisitions in the Past Five Years
Table 66. Global Biosimilars of Rituximab Sales by Region (2017-2022) & (K Units)
Table 67. Global Biosimilars of Rituximab Sales by Region (2023-2028) & (K Units)
Table 68. Global Biosimilars of Rituximab Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Biosimilars of Rituximab Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)
Table 71. Global Biosimilars of Rituximab Sales by Type (2023-2028) & (K Units)
Table 72. Global Biosimilars of Rituximab Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Biosimilars of Rituximab Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Biosimilars of Rituximab Price by Type (2017-2022) & (US$/Unit)
Table 75. Global Biosimilars of Rituximab Price by Type (2023-2028) & (US$/Unit)
Table 76. Global Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)
Table 77. Global Biosimilars of Rituximab Sales by Application (2023-2028) & (K Units)
Table 78. Global Biosimilars of Rituximab Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Biosimilars of Rituximab Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Biosimilars of Rituximab Price by Application (2017-2022) & (US$/Unit)
Table 81. Global Biosimilars of Rituximab Price by Application (2023-2028) & (US$/Unit)
Table 82. North America Biosimilars of Rituximab Sales by Country (2017-2022) & (K Units)
Table 83. North America Biosimilars of Rituximab Sales by Country (2023-2028) & (K Units)
Table 84. North America Biosimilars of Rituximab Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Biosimilars of Rituximab Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)
Table 87. North America Biosimilars of Rituximab Sales by Type (2023-2028) & (K Units)
Table 88. North America Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)
Table 89. North America Biosimilars of Rituximab Sales by Application (2023-2028) & (K Units)
Table 90. Europe Biosimilars of Rituximab Sales by Country (2017-2022) & (K Units)
Table 91. Europe Biosimilars of Rituximab Sales by Country (2023-2028) & (K Units)
Table 92. Europe Biosimilars of Rituximab Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Biosimilars of Rituximab Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)
Table 95. Europe Biosimilars of Rituximab Sales by Type (2023-2028) & (K Units)
Table 96. Europe Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)
Table 97. Europe Biosimilars of Rituximab Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Biosimilars of Rituximab Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Biosimilars of Rituximab Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Biosimilars of Rituximab Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Biosimilars of Rituximab Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Biosimilars of Rituximab Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Biosimilars of Rituximab Sales by Application (2023-2028) & (K Units)
Table 106. South America Biosimilars of Rituximab Sales by Country (2017-2022) & (K Units)
Table 107. South America Biosimilars of Rituximab Sales by Country (2023-2028) & (K Units)
Table 108. South America Biosimilars of Rituximab Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Biosimilars of Rituximab Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)
Table 111. South America Biosimilars of Rituximab Sales by Type (2023-2028) & (K Units)
Table 112. South America Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)
Table 113. South America Biosimilars of Rituximab Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Biosimilars of Rituximab Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Biosimilars of Rituximab Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Biosimilars of Rituximab Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Biosimilars of Rituximab Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Biosimilars of Rituximab Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Biosimilars of Rituximab Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Biosimilars of Rituximab Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Biosimilars of Rituximab Sales by Application (2023-2028) & (K Units)
Table 122. Biosimilars of Rituximab Raw Material
Table 123. Key Manufacturers of Biosimilars of Rituximab Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Biosimilars of Rituximab Typical Distributors
Table 127. Biosimilars of Rituximab Typical Customers
List of Figures
Figure 1. Biosimilars of Rituximab Picture
Figure 2. Global Biosimilars of Rituximab Revenue Market Share by Type in 2021
Figure 3. 500mg
Figure 4. 100mg
Figure 5. Other
Figure 6. Global Biosimilars of Rituximab Revenue Market Share by Application in 2021
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Global Biosimilars of Rituximab Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Biosimilars of Rituximab Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Biosimilars of Rituximab Sales (2017-2028) & (K Units)
Figure 12. Global Biosimilars of Rituximab Price (2017-2028) & (US$/Unit)
Figure 13. Global Biosimilars of Rituximab Production Capacity (2017-2028) & (K Units)
Figure 14. Global Biosimilars of Rituximab Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Biosimilars of Rituximab Market Drivers
Figure 16. Biosimilars of Rituximab Market Restraints
Figure 17. Biosimilars of Rituximab Market Trends
Figure 18. Global Biosimilars of Rituximab Sales Market Share by Manufacturer in 2021
Figure 19. Global Biosimilars of Rituximab Revenue Market Share by Manufacturer in 2021
Figure 20. Biosimilars of Rituximab Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Biosimilars of Rituximab Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Biosimilars of Rituximab Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Biosimilars of Rituximab Sales Market Share by Region (2017-2028)
Figure 24. Global Biosimilars of Rituximab Revenue Market Share by Region (2017-2028)
Figure 25. North America Biosimilars of Rituximab Revenue (2017-2028) & (USD Million)
Figure 26. Europe Biosimilars of Rituximab Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Biosimilars of Rituximab Revenue (2017-2028) & (USD Million)
Figure 28. South America Biosimilars of Rituximab Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Biosimilars of Rituximab Revenue (2017-2028) & (USD Million)
Figure 30. Global Biosimilars of Rituximab Sales Market Share by Type (2017-2028)
Figure 31. Global Biosimilars of Rituximab Revenue Market Share by Type (2017-2028)
Figure 32. Global Biosimilars of Rituximab Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Biosimilars of Rituximab Sales Market Share by Application (2017-2028)
Figure 34. Global Biosimilars of Rituximab Revenue Market Share by Application (2017-2028)
Figure 35. Global Biosimilars of Rituximab Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Biosimilars of Rituximab Sales Market Share by Type (2017-2028)
Figure 37. North America Biosimilars of Rituximab Sales Market Share by Application (2017-2028)
Figure 38. North America Biosimilars of Rituximab Sales Market Share by Country (2017-2028)
Figure 39. North America Biosimilars of Rituximab Revenue Market Share by Country (2017-2028)
Figure 40. United States Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Biosimilars of Rituximab Sales Market Share by Type (2017-2028)
Figure 44. Europe Biosimilars of Rituximab Sales Market Share by Application (2017-2028)
Figure 45. Europe Biosimilars of Rituximab Sales Market Share by Country (2017-2028)
Figure 46. Europe Biosimilars of Rituximab Revenue Market Share by Country (2017-2028)
Figure 47. Germany Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Biosimilars of Rituximab Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Biosimilars of Rituximab Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Biosimilars of Rituximab Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Biosimilars of Rituximab Revenue Market Share by Region (2017-2028)
Figure 56. China Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Biosimilars of Rituximab Sales Market Share by Type (2017-2028)
Figure 63. South America Biosimilars of Rituximab Sales Market Share by Application (2017-2028)
Figure 64. South America Biosimilars of Rituximab Sales Market Share by Country (2017-2028)
Figure 65. South America Biosimilars of Rituximab Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Biosimilars of Rituximab Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Biosimilars of Rituximab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Biosimilars of Rituximab in 2021
Figure 77. Manufacturing Process Analysis of Biosimilars of Rituximab
Figure 78. Biosimilars of Rituximab Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • リツキシマブ医薬品のグローバル市場展望 2023年-2029年：10ml、50ml
  • リツキシマブのグローバル市場展望 2023年-2029年：10ml、50ml
  • 世界の血漿分画装置市場2022年：市場規模予測（～2028年）
  • 世界の経口用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）
  • 世界の使い捨て型歯科滅菌針市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19178 )"世界のリツキシマブ用バイオシミラー市場2022年：市場規模予測（～2028年）" (英文：Global Biosimilars of Rituximab Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。